Private Trust Co. NA Lowers Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Private Trust Co. NA reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 18.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,935 shares of the real estate investment trust’s stock after selling 1,615 shares during the period. Private Trust Co. NA’s holdings in Healthpeak Properties were worth $141,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of DOC. State Street Corp bought a new position in Healthpeak Properties in the 3rd quarter worth about $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at about $403,898,000. Principal Financial Group Inc. raised its holdings in Healthpeak Properties by 2,113.5% in the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares during the last quarter. Charles Schwab Investment Management Inc. bought a new position in shares of Healthpeak Properties in the third quarter worth approximately $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $175,697,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

DOC opened at $20.30 on Wednesday. The company’s 50 day moving average is $20.19 and its 200 day moving average is $21.32. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market cap of $14.20 billion, a price-to-earnings ratio of 57.99, a PEG ratio of 2.17 and a beta of 1.15. Healthpeak Properties, Inc. has a 12-month low of $16.66 and a 12-month high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 6.01%. The ex-dividend date of this dividend was Friday, February 14th. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Analyst Ratings Changes

A number of brokerages recently weighed in on DOC. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. Scotiabank decreased their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Mizuho lowered their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Wedbush reduced their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Finally, Robert W. Baird lowered their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.